Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.
about
The influence of the human microbiome and probiotics on cardiovascular healthUnmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studiesDoes Age Matter? Association Between Usual Source of Care and Hypertension Control in the US Population: Data From NHANES 2007-2012Lipid, blood pressure and kidney update 2013.Characterization of diabetes risk factors in patients prescribed chronic statin therapy.Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals.Blood glucose screening rates among Minnesota adults with hypertension, Behavioral Risk Factor Surveillance System, 2011.Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010.The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010Role of community health outreach program "living for health" in improving access to federally qualified health centers in Miami-dade county, Florida: a cross-sectional study.Management of Type 2 Diabetes Mellitus through TelemedicineHigh Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.Socioeconomic Characteristics Are Major Contributors to Ethnic Differences in Health Status in Obstructive Lung Disease: An Analysis of the National Health and Nutrition Examination Survey 2007-2010.Diabetes and age-related demographic differences in risk factor control.The blood pressure lowering potential of sulodexide--a systematic review and meta-analysisGender differences in hypertension and hypertension awareness among young adults.Greater decreases in cholesterol levels among individuals with high cardiovascular risk than among the general population: the northern Sweden MONICA study 1994 to 2014.2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals.Blood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies.The Current Situation of Hypertension among Rural Minimal Assurance Family Participants in Liaoning (China): A Cross-Sectional Study.Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study.Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease.Prevention of cardiovascular disease: highlights for the clinician of the 2013 American College of Cardiology/American Heart Association guidelines.Treatment of hypertension with chronotherapy: is it time of drug administration?Prehypertension--prevalence, health risks, and management strategies.Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects.Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network.Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry.Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.Effectiveness of a tailored behavioral intervention to improve hypertension control.Racial and insurance based disparities in the treatment of carotid artery stenosis: a study of the Nationwide Inpatient Sample.Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks.Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
P2860
Q26992191-578BC12F-713E-40DA-8742-6C505F6CE986Q28072161-B754B457-BAB2-4C55-869D-44EC991D7FF5Q31046561-23B80DDE-50E9-4349-A843-99FC6A3EA919Q33574532-6A9B4E27-6983-414A-8167-5D846F7FD37EQ34039706-E8A2D74F-6464-47B7-AFE7-B83ACB5A19A7Q34459136-36C3A00F-3571-449F-9D72-9A441F5DC8BAQ34584279-F76F1942-BF39-489A-B493-250D555D8339Q35549703-7FCFCB17-285B-4819-9B29-92456C054B35Q35551467-FF93ADCD-8A57-42A5-9F8C-DCDA79333577Q35559509-91E37170-4E95-438C-AE40-3EC141FE4DCDQ35606695-16484906-8910-49AD-9650-6C64E68847F1Q35606860-07884571-4F36-4AB5-9E33-D1B8080AE5D1Q35825590-712416EA-8F3F-4070-B89C-6CAA6C11C62CQ36354488-F0223013-923F-4DDE-96C8-FBF7024616E9Q36410118-25FA151F-AAC1-4DA6-AEF7-536B49433493Q36978242-DB9C67AA-C7A8-4518-9367-F7927B798D5DQ37057106-7B837698-664E-482D-A944-21710DE0D8E9Q37240391-77165A5D-8EFD-4682-9823-5DF505EE7A0DQ37334943-AB1E5774-825F-4C7F-9540-25BE06A5F02DQ37546429-2D16A654-F0F8-43E2-B27B-BE05DBE055B7Q37625869-771EB4E7-EB70-4CD4-9057-D22A8F9008F4Q37657406-838E65A9-B339-4627-9499-F2C241CFF212Q38196342-CAAAEA32-BA31-4EFD-A1D9-1211FB346405Q38291112-201799D4-1AD5-4A37-8ADE-1AC69C19C8ADQ38357890-14B2B354-2D67-4DB0-BCE7-E11165CA8DFAQ38373217-78D58838-2E3D-4A2E-8FD6-42AE50288307Q38524257-3C2D92F0-F8FE-44FE-850E-B0701872FCB6Q38682312-EB861F7B-15C4-4D8C-864C-EABB3083A3FAQ40089042-B462F6AD-43C3-4452-AF7F-FC2FC3DD9434Q40142545-16C39EE3-49B1-4912-BD58-516A4F73B576Q40275485-7917585A-1FFC-4628-9F2C-90F769355C53Q41190859-B28299C4-FE7C-4512-9903-62FC4F49C2F7Q43099169-6F7AF55A-8789-47C4-908C-72B137BBA62EQ45145646-42DE0E53-9F7C-482D-8BC9-476930492E9CQ46926321-12BA677D-403F-47B9-9302-39892EBA8D5DQ47599452-18158DC4-CBD5-4F80-9232-412A7A0162AFQ50917764-500FA900-84EE-43B0-A4AF-49A8AAA278A4Q59126269-640CE8B1-B876-41FE-8736-DABC4EA4FD08
P2860
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@ast
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@en
type
label
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@ast
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@en
prefLabel
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@ast
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@en
P2093
P2860
P1433
P1476
Blood pressure and cholesterol ...... examination surveys 1988-2010.
@en
P2093
Brent M Egan
Jiexiang Li
Suparna Qanungo
Tamara E Wolfman
P2860
P356
10.1161/CIRCULATIONAHA.112.000500
P407
P577
2013-07-01T00:00:00Z